A case of metastatic basal cell carcinoma treated with carboplatin and paclitaxel
Saved in:
Main Authors: | Chryssoula Papageorgiou (Author), Zoe Apalla (Author), Eleni Timotheadou (Author), Konstantia Loga (Author), Elizabeth Lazaridou (Author), Dimitrios Dionysopoulos (Author) |
---|---|
Format: | Book |
Published: |
Mattioli1885,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic impact of adding bevacizumab to carboplatin and paclitaxel for recurrent, persistent, or metastatic cervical cancer
by: Masafumi Yasunaga, et al.
Published: (2022) -
Dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin treatment for stage II-IV ovarian cancer patients
by: Zhenhua Du, et al.
Published: (2015) -
Spotlight on vismodegib in the treatment of basal cell carcinoma: an evidence-based review of its place in therapy
by: Apalla Z, et al.
Published: (2017) -
Durable remission in a patient with ERBB2-amplified recurrent mucinous ovarian carcinoma treated with Trastuzumab-Carboplatin-Paclitaxel
by: Alexander J. Neil, et al.
Published: (2023) -
The Impact of Immune Checkpoint Inhibitors-Induced Skin Toxicity on Patients' Quality of Life and the Role of Dermatologic Intervention
by: Christina Kemanetzi, et al.
Published: (2024)